Morgan Stanley Lowers C3.ai Price Target to $6

Analyst: Sanjit Singh 1 min read Reproduced verbatim
Rating
Underweight
Target
$6
from $11 (−45%)
Downside
−47%
AI at $11.38 today
Morgan Stanley and C3.ai logos

What the analyst said

Morgan Stanley analyst Sanjit Singh lowered the price target on C3.ai (NYSE: AI) to $6.00 (from $11.00) while maintaining an Underweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AI trades at $11.38. The 3 analysts who set a target in the last 3 months range from $7 to $12.50, with a median of $12. This $6 target is 50% below the median, the lowest on the Street.

Since the note AI has moved +10% (from $10.31). 12-month window: day 252 of 365, closes on February 26, 2027.

Track record

This callOpen: AI has not reached $6 yet. This 12-month target is scored on February 26, 2027.

Firm track recordMorgan Stanley: 82% of its 49 targets at least a year old were reached within 12 months (#8 of 26 firms). Accuracy ranking →

Earnings reactionOne of 7 notes after C3.ai’s Feb 25 results: 0 raised · 7 cut · 0 kept. See every call →

Morgan Stanley on C3.ai

Morgan Stanley price targets on C3.ai

2 calls from February 26, 2026 to June 4, 2026. The target went from $6 to $7 (+17%). The rating stayed Sell.

Morgan Stanley targetAI share price
  1. June 4, 2026Target raised from $6 (+17%)Sell$7
  2. February 26, 2026 This noteEarliest call shownSell$6
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.